“Two percent,” he said quietly. “That’s not a failure margin. That’s where the old wisdom lives.”
He rubbed his eyes. Two percent. That was the razor’s edge between a breakthrough generic for a life-saving anti-coagulant and complete failure. For six months, the R&D team had been stuck. Millions of rupees had evaporated into solvents, binders, and failed crystallization processes. The board was losing patience. His predecessor had resigned over this very molecule. veriton pharma limited
“I want you to look at the principle ,” Meera insisted. “He solved pH sensitivity without synthetic polymers. We’ve been trying to build a Ferrari. Maybe we just need a reliable bullock cart.” “Two percent,” he said quietly
© 2015 Playtime Kft.
